Highland Oncology Group

Fayetteville, Arkansas 72703

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Multiple Myeloma

Studies at this site

• Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer — Stopped early
• Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients — Completed